Literature DB >> 10551323

Localization of a target region of allelic loss to a 1-cM interval on chromosome 16p.13.13 in hepatocellular carcinoma.

M Koyama1, H Nagai, K Bando, M Ito, Y Moriyama, M Emi.   

Abstract

To identify the location of the putative tumor suppressor gene on chromosome 16p that may be involved in hepatocellular carcinoma (HCC), we examined 96 primary HCCs and evaluated their patterns of allelic loss at 10 microsatellite marker loci distributed along this chromosome arm. Allelic loss at one or more loci was observed in 46 (48%) of these tumors. Through detailed deletion mapping of tumors having partial or interstitial deletions, we identified a commonly deleted region at a 1-cM interval, flanked by D16S519 and D16S3078 at 16p13.13, defining the location of a putative tumor suppressor gene for HCC. This region contains the gene for JAB (JAK-binding protein), which is responsible for negative-feedback regulation of the JAK-STAT pathway induced by cytokine stimulation, raising the possibility that inactivation of this gene may participate in hepatocarcinogenesis via genetic and/or epigenetic changes.

Entities:  

Mesh:

Year:  1999        PMID: 10551323      PMCID: PMC5926168          DOI: 10.1111/j.1349-7006.1999.tb00840.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  34 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Mapping of the human GSPT1 gene, a human homolog of the yeast GST1 gene, to chromosomal band 16p13.1.

Authors:  K Ozawa; Y Murakami; T Eki; K Yokoyama; E Soeda; S Hoshino; M Ui; F Hanaoka
Journal:  Somat Cell Mol Genet       Date:  1992-03

3.  Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas.

Authors:  H P Wang; C E Rogler
Journal:  Cytogenet Cell Genet       Date:  1988

4.  Assignment of the gene for a ubiquitin-conjugating enzyme (UBE2I) to human chromosome band 16p13.3 by in situ hybridization.

Authors:  M Tachibana; N Iwata; A Watanabe; Y Nobukuni; B Ploplis; S Kajigaya
Journal:  Cytogenet Cell Genet       Date:  1996

5.  A comprehensive genetic map of the human genome based on 5,264 microsatellites.

Authors:  C Dib; S Fauré; C Fizames; D Samson; N Drouot; A Vignal; P Millasseau; S Marc; J Hazan; E Seboun; M Lathrop; G Gyapay; J Morissette; J Weissenbach
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

Review 6.  Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis.

Authors:  K Matsubara; T Tokino
Journal:  Mol Biol Med       Date:  1990-06

7.  Isolation and mapping of a polymorphic CA repeat sequence at the human interleukin 6 locus.

Authors:  K Tsukamoto; K Haruta; T Shiba; M Emi
Journal:  J Hum Genet       Date:  1998       Impact factor: 3.172

8.  M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity.

Authors:  A T De Souza; G R Hankins; M K Washington; T C Orton; R L Jirtle
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

9.  Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis.

Authors:  Y Kanai; S Ushijima; H Tsuda; M Sakamoto; T Sugimura; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1996-12

10.  Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma.

Authors:  W D Zhang; S Hirohashi; H Tsuda; Y Shimosato; J Yokota; M Terada; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1990-02
View more
  3 in total

1.  Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology.

Authors:  J Cui; D H Yang; X J Bi; Z R Fan
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Activation of STAT3 signaling in human stomach adenocarcinoma drug-resistant cell line and its relationship with expression of vascular endothelial growth factor.

Authors:  Li-Fen Yu; Ying Cheng; Min-Min Qiao; Yong-Ping Zhang; Yun-Lin Wu
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

3.  No evidence for the JAK2 (V617F) or JAK2 exon 12 mutations in primary mediastinal large B-cell lymphoma.

Authors:  David Wu; Bethany Dutra; Neal Lindeman; Hidenobu Takahashi; Kunihiko Takeyama; Nancy L Harris; Geraldine S Pinkus; Janina Longtine; Margaret Shipp; Jeffery L Kutok
Journal:  Diagn Mol Pathol       Date:  2009-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.